About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Check-Cap Ltd.
MBAINASDAQHealthcareDiagnostics & Research
$2.75Today:- (-)1Y +70.33%
As of Oct 16, 2026 close
- Market cap
- $66.58M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.21$14.70
- Volume (live)
- -
- Avg. volume (3M)
- 22.14K
Check-Cap (MBAI) Company Profile
Complete business overview, executive team, trading details, and corporate information.
Check-Cap Ltd.
MBAI•Nasdaq Stock Market•Healthcare•Diagnostics & Research
Company Information
SectorHealthcare
IndustryDiagnostics & Research
CEODavid Lontini
Founded2004
Employees85
CountryIsrael
Fiscal YearJanuary - December
Stock Details
ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
Contact Information
Websitecheck-cap.com
Phone972 4 830 3400
Address29 Abba Hushi Avenue, P.O.Box 1271
Isfiya, 3009000
Israel
Corporate Identifiers
CIK0001610590
CUSIP001133685
ISINIL0011336851
Leadership Team & Key Executives
David Lontini
Interim Chief Executive Officer and Chairman of the Board
Alan Lewis
Chief Financial Officer
Noa Reshef M.B.A.
Head of Operations